Gemtesa 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FC1F8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,111
Award facts
- Contract value 100% obligated
- $22,110.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $22,110.99 delivery order to Amerisourcebergen Drug Corp on July 9, 2026, for Gemtesa 75 mg tablets (30-count units) under firm fixed-price terms, with ultimate completion on July 10, 2026.
Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to Department of Defense and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FC1F8?
SPE2DR26FC1F8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 9, 2026.
How much is contract SPE2DR26FC1F8 worth?
The government has obligated $22,111 on SPE2DR26FC1F8.
Is contract SPE2DR26FC1F8 an order under another contract?
Yes. SPE2DR26FC1F8 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FC1F8 competed?
The extent of competition for SPE2DR26FC1F8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award